NCT01365169
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +89 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Stage III Nasopharyngeal Carcinoma AJCC v7
Explore clinical trials studying Stage III Nasopharyngeal Carcinoma AJCC v7. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Stage III Nasopharyngeal Carcinoma AJCC v7 trial results
Active, not recruiting
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NCT02135042
- Conditions
- Carcinoma, DNA Virus Infections, EBV Infection, +22 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
Active, not recruiting
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
NCT03074513
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +63 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02339558
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +18 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Keck Medical Center of USC Pasadena Pasadena, California, United States